GOLM1 and hepatocellular carcinoma: In contrast, patients with positivity for both GP73 and COMP who were followed for more than 6 months had significantly higher rates of HCC development either in the total patients’ group (n = 229; P < 0.001; Figure 5A) or in those with established cirrhosis at baseline (n = 82; P < 0.001).